Sep 28

SS 15 - Immunotherapy Integration and Immuno Biomarkers Across Mucosal and Cutaneous SCC

1057 - Stereotactic Body Radiotherapy Combined with Chemotherapy and PD-1 Inhibitor in Oligometastatic Nasopharyngeal Carcinoma (STOMP): A Prospective Phase II Clinical Trial

11:35am - 11:45am ET

Presenter(s)

Jingjing Miao, PhD, MS, BS - Sun Yat-sen University Cancer Center, Guangzhou, Guangdong